SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
July 12, 2000
Date of Report (Date of earliest event reported)
Nastech Pharmaceutical Company Inc.
(Exact name of Registrant as specified in its charter)
Delaware 000-13789 11-2658569
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification Number)
45 Davids Drive
Hauppauge, NY 11788
(Address of principal executive offices)
(631) 273-0101
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On July 12, 2000, Registrant issued a press release to announce that
it had entered into an equity line of credit that will allow it to sell to an
investor, at the Registrant's discretion, up to 1.2 million common shares over
the next three years. The common shares will be sold to the investor at a
discount to the market price at the time of sale. The equity line of credit is
conditioned upon the effectiveness of a registration statement that the Company
will file with the Securities and Exchange Commission within the next 45 days.
Any common shares sold to the investor will be registered on such registration
statement and will be resold by means of a current prospectus.
Item 7. Financial Statements, Pro Forma Financial Statements and Exhibits
(c) Exhibits:
99.1 Press Release dated July 12, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Nastech Pharmaceutical Company Inc.
By: /s/ Bruce R. Thaw
----------------------------------
Name: Bruce R. Thaw
Title: Director
Member of Executive Committee
By: /s/ Andrew Zinzi
----------------------------------
Name: Andrew Zinzi
Title: Chief Financial Officer
Principal Financial and Accounting Officer
Date: July 18, 2000
<PAGE>
Exhibit Index
Exhibit Number Description
-------------- -----------
99.1 Press Release dated July 12, 2000.
